Skip to main content
OpenTrials

Clinical trial condition

Neurofibromatosis 2

Explore clinical trials studying Neurofibromatosis 2. Study availability and eligibility vary by location and protocol.

37 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Neurofibromatosis 2 trial results

Completed

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

NCT04283669

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations
  • The University of Alabama at Birmingham (Site 700) Birmingham, Alabama, United States
  • Univ of California @ Los Angeles (Site 325) Los Angeles, California, United States
  • Children's National Medical Center (Site 775) Washington D.C., District of Columbia, United States
  • Children's HealthCare of Atlanta (Site 950) Atlanta, Georgia, United States
View all 15 locations
View Trial Details
Completed

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

NCT01767792

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +26 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's HealthCare of Atlanta Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

NCT01125046

Conditions
Acoustic Schwannoma, Adult Anaplastic Meningioma, Adult Ependymoma, +51 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • University of Virginia Charlottesville, Virginia, United States
View Trial Details

Related conditions